Korean J Dermatol.  2010 Dec;48(12):1132-1135.

Hypertrophic Lupus Erythematosus Successfully Treated with Triamcinolone Intralesional Injection

Affiliations
  • 1Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Korea. yageyage@medimail.co.kr

Abstract

Hypertrophic lupus erythematosus (HLE) is a distinct and rare clinical variant of chronic cutaneous lupus erythematosus (CCLE). It is characterized by verrucous lesions and a chronic course of disease. HLE tends to be much more refractory to treatment than classical CCLE. Therefore, the traditionally available therapeutic options including sun protection, topical and oral corticosteroids, hydroxychloroquine, retinoid and thalidomide are often unable to control the disease. We report here on the successful use of triamcinolone intralesional injection in a patient with HLE and who failed to respond to conventional treatment such as acitretin and hydroxychloroquine.

Keyword

Hypertrophic lupus erythematosus; Triamcinolone

MeSH Terms

Acitretin
Adrenal Cortex Hormones
Humans
Hydroxychloroquine
Injections, Intralesional
Lupus Erythematosus, Cutaneous
Solar System
Thalidomide
Triamcinolone
Acitretin
Adrenal Cortex Hormones
Hydroxychloroquine
Thalidomide
Triamcinolone
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr